Article
Time of drug administration, CYP3A5 and ABCB1 genotypes, and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study.
Therapeutic drug monitoring - 1 Dec 2009
Musuamba Flora Tshinanu, Mourad Michel, Haufroid Vincent, Delattre Isabelle Karine, Verbeeck Roger Karel, Wallemacq Pierre
Abstract excerpt
Tacrolimus (TAC) pharmacokinetics are characterized by a very high variability that complicates its therapeutic use. The aims of this study were: 1) to identify and model the effect of demographic, clinical, and genetic factors and time of drug administration on TAC pharmacokinetic variability; and 2) to assess the influence of the analytical method by modeling the TAC blood concentrations measured simultaneously...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
